Sofosbuvir and Valsartan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sofosbuvir (sofosbuvir) and Valsartan (valsartan). Common drug interactions include abdominal pain among females and coronary artery stenosis among males.

The phase IV clinical study analyzes what interactions people have when they take Sofosbuvir and Valsartan. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Sofosbuvir?

Sofosbuvir has active ingredients of sofosbuvir. eHealthMe is studying from 9,194 Sofosbuvir users. Check the latest studies of Sofosbuvir.

What is Valsartan?

Valsartan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 63,805 Valsartan users. Check the latest studies of Valsartan.

On Aug, 05, 2026

22 people who take Sofosbuvir and Valsartan together, and have interactions are studied.

Sofosbuvir and Valsartan drug interactions.

What are the common drug interactions of Sofosbuvir and Valsartan, by gender? *:

female:

Abdominal pain
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Vasculitis (inflammation of a blood vessel or blood vessels)
Ascites (accumulation of fluid in the abdominal cavity)
Calculus ureteric (stone in ureter)
Cardiac failure congestive
Cellulitis (infection under the skin)
Chest discomfort
Constipation
Cough

male:

Coronary artery stenosis (narrowing of coronary artery)
Oedema peripheral (superficial swelling)
Priapism (prolonged and painful erection that can last from several hours up to a few days)
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
Skin exfoliation (removal of the oldest dead skin cells)
Vertigo
Chest pain
Dizziness
Fatigue (feeling of tiredness)
Haemoglobin decreased

What are the common drug interactions of Sofosbuvir and Valsartan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)

50-59:

Coronary artery stenosis (narrowing of coronary artery)
Oedema peripheral (superficial swelling)
Chest pain
Dizziness
Fatigue (feeling of tiredness)
Haemoglobin decreased
Influenza like illness
Abdominal pain
Arthralgia (joint pain)
Burning sensation

60+:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Vasculitis (inflammation of a blood vessel or blood vessels)
Suicide attempt
Upper respiratory tract infection
Visual impairment
Ascites (accumulation of fluid in the abdominal cavity)
Cardiac failure congestive
Chest discomfort
Cough
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

What are the existing conditions these people have? *

Hepatitis C: 12 people, 54.55%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 2 people, 9.09%
Glomerulonephritis Rapidly Progressive (a syndrome of the kidney that is characterized by a rapid loss of renal function): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Sofosbuvir and Valsartan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously